Following the market opening Thursday, the Dow traded down 0.45% to 34,657.69 while the NASDAQ fell 0.66% to 15,061.97. The S&P also fell, dropping 0.62% to 4,453.04.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 41,539,100 cases with around 666,620 deaths. India confirmed a total of at least 33,347,320 cases and 443,920 deaths, while Brazil reported over 21,034,610 COVID-19 cases with 588,590 deaths. In total, there were at least 226,445,290 cases of COVID-19 worldwide with more than 4,661,150 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Financials shares slipped by just 0.2% on Thursday. Meanwhile, top gainers in the sector included Great Western Bancorp, Inc. GQB, up 12% and Metropolitan Bank Holding Corp. MCB up 7%.
In trading on Thursday, materials shares tumbled 1.2%.
Top Headline
US retail sales increased 0.7% in August of 2021, following a revised 1.8% decline in July. Analysts were expecting for a 0.8% decline in retail trade.
Equities Trading UP
IronNet Cybersecurity, Inc. IRNT shares shot up 32% to $42.44 amid increased retail investor interest in the stock on social media.
Shares of Dutch Bros Inc. BROS got a boost, shooting 24% to $45.59. Dutch Bros shares surged around 60% on Wednesday in its public debut.
TMC the metals company Inc. TMC shares were also up, gaining 24% to $12.35 amid increased retail investor interest in the stock on social media.
Check out these big movers of the day
Equities Trading DOWN
Silverback Therapeutics, Inc. SBTX shares tumbled 27% to $11.82. The company presented interim clinical results from a Phase 1/1b clinical study of SBT6050 as a monotherapy and in combination with Merck & Co's Keytruda in patients with advanced or metastatic HER2-expressing or amplified solid tumors.
Shares of Aerie Pharmaceuticals, Inc. AERI were down 24% to $11.87 after the company announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry eye disease. The company said that the study failed to achieve statistical significance at pre-determined primary endpoints at Day 28.
MacroGenics, Inc. MGNX was down, falling 19% to $22.39 as the company disclosed results from Cohort A Part 1 of the Phase 2/3 MAHOGANY clinical trial of margetuximab.
Commodities
In commodity news, oil traded down 0.3% to $72.41, while gold traded down 1% to $1,776.10.
Silver traded down 1.5% Thursday to $23.445 while copper fell 2% to $4.3180.
Euro zone
European shares were higher today. The eurozone’s STOXX 600 gained 0.7%, the Spanish Ibex Index rose 0.9% and the German DAX 30 gained 0.6%. Meanwhile, the London’s FTSE 100 rose 0.4%, French CAC 40 climbed 1.1% and Italy’s FTSE MIB jumped 1.1%.
The Eurozone trade surplus shrank to EUR 20.7 billion in July from EUR 26.8 billion in the year-ago period, while passenger car registrations in the European Union dropped 19.1% year-over-year to 623 thousand units in August. Italy’s trade surplus narrowed to EUR 8.762 billion in July from EUR 9.689 billion in the year-ago month.
Economics
US initial jobless claims increased to 332 thousand in the week ending September 11 versus a reading of 312 thousand in the previous week.
The Philadelphia Fed manufacturing index climbed to 30.7 in September from 19.4 in August.
Retail sales increased 0.7% in August of 2021, following a revised 1.8% decline in July.
US business inventories rose 0.5% for July.
The Energy Information Administration’s weekly report on natural gas stocks in underground storage is scheduled for release at 10:30 a.m. ET.
The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.
The Treasury International Capital report for July will be released at 4:00 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
